Agenda
TUESDAY, MARCH 31
All Times - EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dr. Ronan O'Hagan, CEO, Bectas Therapeutics | Former Executive Director, Oncology Drug Discovery for Merck | Former CSO, Xilio Therapeutics. Topic: The Latest in Drug Discovery and Development
9:40am // Corporate Presentation - IMUNON (Nasdq: IMNN)
9:55am // Corporate Presentation - Hua Medicine (HKEX:2552)
10:10am // Corporate Presentation - Bectas Therapeutics
10:25am // Corporate Presentation - MAXONA Pharmaceutical
10:40am // Corporate Presentation - Alphyn Biologics
10:55am // Corporate Presentation - DNA Nanobots
11:10am // Corporate Presentation - Rejuvenation Technologies
11:25am // Corporate Presentation - Vesselon
11:40am // Corporate Presentation - OBI Pharma
11:55am // Corporate Presentation - Duo Oncology
12:10pm // Corporate Presentation - Imbrium Therapeutics
12:25pm // LUNCH BREAK
1:20pm // Corporate Presentation - Stingray Therapeutics
1:35pm // Corporate Presentation - RealNose
1:50pm // Corporate Presentation - PredxBio
2:05pm // Corporate Presentation - Sustained Therapeutics
2:20pm // Corporate Presentation - Maipl Therapeutics
2:35pm // Corporate Presentation - Galibra Neuroscience
2:50pm // Corporate Presentation - Allander Biotechnologies
3:05pm // Corporate Presentation - LightOx
3:20pm // Corporate Presentation - Cytodyn
3:35pm // Corporate Presentation - Apricity Health
3:50pm // SPEAKERS - Steven Ferguson, Deputy Director, Deputy Director, Licensing and Entrepreneurship, NIH; Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU). Topic: NIH as Your Strategic Partner: Beyond Funding to Market Success
4:20pm // SPEAKER - Steven Green, Partner, Pillsbury. Topic: Founder Power vs. Fiduciary Risk: Series A Governance After Moelis, §144, and Tesla
4:45pm // SPEAKER - Dr. Phil Friedlander, Professor, Medicine, Hematology and Medical Oncology, Mt. Sinai | Lead PI Iovance Trial
5:15pm // PANEL - VENTURE CAPITAL INVESTOR PANEL Moderator: Bill Werkmeister. Panelists: Allan Gobbs, Founder & Managing Partner, ATEM Capital; Brooke Raphael, COO, Avicella Capital; Max Colbert, Associate, Medical Excellence Capital
6:00pm // CLOSING REMARKS
6:10pm // RECEPTION
WEDNESDAY, APRIL 1, 2026
All Times - EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dr. Alfred Slanetz, Former CEO, Bluebird Bio | Chairman, National Foundation for Cancer Research. Topic: Bluebird Bio: What Went Right, What Went Wrong
9:40am // Corporate Presentation - Geneius Biotechnology
9:55am // Corporate Presentation - ScorePharma
10:10am // Corporate Presentation - Oban BioPharma
10:25am // Corporate Presentation - Ridgeline Therapeutics
10:40am // Corporate Presentation - SciTech Development
10:55am // Corporate Presentation - Illumen Therapeutics
11:10am // Corporate Presentation - Canary Cure
11:25am // Corporate Presentation - Zena Therapeutics
11:40am // Corporate Presentation - PAVAJ Vascular
11:55am // Corporate Presentation - DigiTwin
12:10pm // Corporate Presentation - rHealth
12:25pm // LUNCH BREAK
1:10pm // Corporate Presentation - KAHR Bio
1:25pm // Corporate Presentation - AltrixBio
1:40pm // Corporate Presentation -
1:55pm // Corporate Presentation -
2:10pm // BREAK
2:40pm // Corporate Presentation -
2:55pm // Corporate Presentation -
3:10pm // Corporate Presentation - Rhythm Biotherapeutics
3:25pm // SPEAKER - Robert Bedgood. Partner, Pillsbury. Topic: IP Law Updates 2026
3:50pm // SPEAKER - Dr. Darryl Davis, Professor, University of Ottawa. Topic: Exosomes in the Cardiac Space
4:20pm // FAMILY OFFICE PANEL DISCUSSION. Moderator: Bill Werkmeister. Panelists: Steven Abernathy, Founder and CEO, Abernathy Family Office; Sherry Grisewood, Senior Investment Officer, FoxHill Asset Management; Dan FarrelL, Founder and CEO, Privos Capital
5:00pm // CLOSING REMARKS
5:10pm // RECEPTION